Iman Daryaei

Dr. Iman Daryaei is a visionary biotech entrepreneur and radiopharmaceutical scientist dedicated to advancing molecular imaging and targeted therapy through innovation and translational excellence. As Founder and CEO of TheraCea Pharma, he leads the development of novel ¹⁸F/²¹²Pb “radiohybrid” theranostic platforms for oncology and neuroinflammation. He also serves as COO of Darya Pharmaceuticals, a preclinical CRO accelerating drug discovery through chemistry, imaging, and regulatory expertise. With academic and industry experience spanning drug discovery to molecular imaging, Dr. Daryaei aims to deliver more effective, precise, and personalized radiopharmaceuticals for improved cancer management.